Levonorgestrel-Releasing Intrauterine System vs. Usual Medical Treatment for Menorrhagia: An Economic Evaluation Alongside a Randomised Controlled Trial

Overview of attention for article published in PLOS ONE, March 2014

Altmetric Badge

Mentioned by

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 11,553 followers.

New @HEU_UoB paper on how choice of EQ5D/SF6D alters treatment recommendation @terobertsbham @SabinaSanghera @EFrew12 http://t.co/60LK1YpMce

New @HEU_UoB paper on how choice of EQ5D/SF6D alters treatment recommendation @terobertsbham @SabinaSanghera @EFrew12 http://t.co/60LK1YpMce

New @HEU_UoB paper on how choice of EQ5D/SF6D alters treatment recommendation @terobertsbham @SabinaSanghera @EFrew12 http://t.co/60LK1YpMce

New @HEU_UoB paper on how choice of EQ5D/SF6D alters treatment recommendation @terobertsbham @SabinaSanghera @EFrew12 http://t.co/60LK1YpMce

New @HEU_UoB paper on how choice of EQ5D/SF6D alters treatment recommendation @terobertsbham @SabinaSanghera @EFrew12 http://t.co/60LK1YpMce

New @HEU_UoB paper on how choice of EQ5D/SF6D alters treatment recommendation @terobertsbham @SabinaSanghera @EFrew12 http://t.co/60LK1YpMce

New @HEU_UoB paper on how choice of EQ5D/SF6D alters treatment recommendation @terobertsbham @SabinaSanghera @EFrew12 http://t.co/60LK1YpMce

New @HEU_UoB paper on how choice of EQ5D/SF6D alters treatment recommendation @terobertsbham @SabinaSanghera @EFrew12 http://t.co/60LK1YpMce